About PSM
Partnership for Safe Medicines statement in response to the New York State Senate’s passage of Senate Bill S604
Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement in response to the New York State Senate’s passage of Senate Bill S604, which would create a wholesale prescription drug importation program in New York.
[...]PSM Supports Parent-led Effort to Rid Social Media of Drug Trafficking
A parent-led commission will release recommendations for social media companies to curb drug dealers on their platforms on September 27th at 1pm Eastern / 10am Pacific.
Register for the launch event.
[...]Partnership for Safe Medicines Statement on Fentanyl Awareness Day August 21st, 2022
The Partnership for Safe Medicines is proud to support Voices for Awareness and Facing Fentanyl as they recognize a national day of remembrance and action to address the widespread threat of counterfeit drugs and illicit fentanyl poisoning. The organization’s founder, Andrea Thomas, lived through the unthinkable when she lost her daughter, Ashley, to fentanyl poisoning in 2018.
[...]Partnership for Safe Medicines Applauds International Criminal Police Organization (INTERPOL) for Seizure of $11 Million in Counterfeit Medicines During Operation Pangea XV
WASHINGTON –The Partnership for Safe Medicines, a public health group committed to the safety of pharmaceutical medicines, applauds the International Criminal Police Organization (INTERPOL) for organizing the seizure of over $11 million in counterfeit medicines during Operation Pangea XV, an initiative to combat the global trafficking of counterfeit pharmaceuticals marketed and sold online. During the…
[...]Partnership for Safe Medicines Statement on Foreign Drug Importation Efforts in the U.S. Senate (updated)
Washington, D.C. (Updated June 13, 2022) – Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, released the following statement in advance of the Senate HELP Committee’s June 14th Executive Session. “The amendments offered to include foreign drug importation in S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, are…
[...]Partnership for Safe Medicines Releases Anti-Counterfeit Public Service Announcement with ADAP Advocacy Association
Washington, D.C. (April 6, 2022) – The Partnership for Safe Medicines has teamed up with the ADAP Advocacy Association (aaa+) to educate people living with HIV on ways they can protect themselves against potential counterfeit medications.
[...]Partnership for Safe Medicines Statement on Synthetic Opioid Trafficking Commission Report
Washington, D.C. (August 12, 2021) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Synthetic Opioid Trafficking Commission’s Final Report
[...]How can families affected by fentanyl or fake medicines become advocates in 2022?
Has your family been affected by fentanyl or fake pills? Learn about opportunities in 2022 to advocate to address the crisis in this webinar about federal legislation this year.
[...]Since 2015, fentanyl has changed the drug landscape
Counterfeit pills made with fentanyl have proliferated across the U.S. since 2015, killing people in all 50 states. The pills have become heavily trafficked, easier to find and more deadly.
This infographic shows how the fentanyl pill trade has changed.
[...]Dr. Marv Shepherd, founding member of PSM, announces retirement from the board
The Board of Directors for the Partnership for Safe Medicines (PSM) announces the retirement of Board President Dr. Marvin D. Shepherd.
[...]